跳至主要内容
临床试验/CTRI/2017/09/009593
CTRI/2017/09/009593已完成3 期

Effect of Oxytocin receptor antagonist in Embryo transfer recipients

Infertility Department0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients >= 23 years of age
  • 2. Body mass index (BMI) of 18.5-38 kg per m2 at screening
  • 3. Normal uterine cavity shown on ultrasound scanning
  • 4. At least one good quality embryo for transfer
  • 5. Basal FSH hormone concentration less than 10 IU/l
  • 6. Patients undergoing IVF-ET using egg donation
  • 7. Patients willing to give written informed consent and willing to comply with the clinical study protocol

排除标准

  • 1. Patients >= 45 years of age
  • 2. Uterine abnormalities that could compromise the implantation process (e.g. fibroids, endometrial polyp, uncorrected hydrosalpinges, adenomyosis)
  • 3. Risk of ovarian hyperstimulation syndrome
  • 4. Patients with a known history of hypersensitivity to the study medication
  • 5. Endocrine disorders (uncorrected thyroid disorders, hyperprolactinaemia)
  • 6. Major organ disorders like liver or kidney failure
  • 7. Patients who are otherwise judged inappropriate for inclusion in the study by the investigator

研究者

发起方
Infertility Department

相似试验